[CHINARD BLOODRPORATION (Incorporated in theyman Islands with limited liability) (NYSE Ticker:) th 48 1 Garden Road Central Hong KongR. NOTICE OF ANNUAL GENERAL MEETING to Be Held on December 19, 2011 (or anyjourned or postponed meeting thereof) To the Shareholders of Chinard Bloodrporation]
[China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2011 HONG KONG, China, October 14, 2011 - China Cord Blood Corporation About China Cord Blood Corporation China Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator]
[China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2011 HONG KONG, China, October 14, 2011 - China Cord Blood Corporation About China Cord Blood Corporation China Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator]
[Chinard Bloodrporation to Hold Annual General Meeting in Hong Kong on December 19, 2011 HONG KONG, China, October 14, 2011 - Chinard Bloodrporationout Chinard Bloodrporation Chinard Bloodrporation is the first and largestrd blood banking operator in China in terms of geographicalverage and is the onlyrd blood banking operator with multiple licenses.Under current government regulations, only]
[Chinard Bloodrporation to Hold Annual General Meeting in Hong Kong on December 19, 2011 HONG KONG, China, October 14, 2011 - Chinard Bloodrporationout Chinard Bloodrporation Chinard Bloodrporation is the first and largestrd blood banking operator in China in terms of geographicalverage and is the onlyrd blood banking operator with multiple licenses.Under current government regulations, only]
[2 Page 5 of Pages CUSIP No. G21107100 SCHEDULE 13D/A 1 NAME OF REPORTING PERSON Golden Meditech Stem Cells (BVI) Company Limited 2]
[2 Page 5 of Pages CUSIP No. G21107100 SCHEDULE 13D/A 1 NAME OF REPORTING PERSON Golden Meditech Stem Cells (BVI) Company Limited 2]
[2 Page 5 of Pages CUSIP No.G21107100HEDULE 13D/A 1 NAME OF REPORTING PERSON Golden Meditech Stem Cells (BVI)mpany Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO 5 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands]
[2 Page 5 of Pages CUSIP No.G21107100HEDULE 13D/A 1 NAME OF REPORTING PERSON Golden Meditech Stem Cells (BVI)mpany Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO 5 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands]
[FORM 20-F ¨ OR x For the fiscal year ended March 31, 2011. OR ¨ OR ¨ Date of event requiring this shell company report: For the transition period from ________ to ________ China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852] [Summary of Loan Agreement Agreement #[ ] Party A (Borrower): Beijing Jiachenhong Biological Technologies, Co., Ltd. Party B (Lender): Huaxia Bank, Beijing Xiushui Branch Article 1 Type of Loan Working Capital Loan Article 2 Amount and Currency of Loan 2.1 The currency of the loan stipulated in the agreement is Renminbi (“RMB”). 2.2 The amount of the loan under this] [CordLife (Hong Kong) Ltd and China Cord Blood Corporation Marketing Collaboration Agreement This Marketing Collaboration Agreement (“Agreement”) is dated the date specified on the execution page of this Agreement. CordLife (Hong Kong) Ltd (“CordLife HK”), 31006823 AND China Cord Blood Corporation ("CCBC"), WHEREAS A. CordLife HK offers services of cord blood stem cell collection, processing, testing and storage services to] [List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Limited People’s Republic of China China Stem Cells (South) Company Limited British Virgin Islands Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. People’s Republic of China China Stem Cells (East) Company Limited China Stem Cells (East) Company] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification CHINA CORD BLOOD CORPORATION September 28, 2011 Ting Zheng Chief Executive Officer September 28, 2011 Albert Chen Chief Financial Officer (Principal Financial and Accounting Officer)] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: Our report dated September 27, 2011 on the consolidated financial statements contains an explanatory paragraph that states the Company completed a share exchange with China Cord Blood Services Corporation (“CCBS”) on June 30, 2009 and the share exchange has been accounted for financial reporting purposes]
